Evidence map›Paper›PMID 42454372›Full record

ArticleNucleic acids research2026

Single-residue engineering of Klenow fragment enables broad acceptance of chemically modified nucleotides.

Tingting Zhang, Song Wang, Jiahui Xu, Yu Zhang, Haiyang Zou, Fengwu Liu, Shangshang Qin, Piet Herdewijn

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tingting ZhangXNA platform, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.ORCID 0009-0002-0794-2909
Song WangXNA platform, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Jiahui XuXNA platform, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Yu ZhangXNA platform, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Haiyang ZouXNA platform, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Fengwu LiuXNA platform, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Shangshang QinXNA platform, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.ORCID 0000-0002-6017-6548
Piet HerdewijnXNA platform, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.ORCID 0000-0003-3589-8503

Funding

Changjiang Scholars ProgramMinistry of Education of ChinaNatural Science Foundation of Henan Province 252300421272
6 · The paper itself

Abstract

Xeno nucleic acids (XNAs) exhibit enhanced chemical stability and significant resistance to nuclease degradation, making them attractive for synthetic biology and therapeutic development. Most engineered XNA polymerases are derived from thermophilic organisms and exhibit limited catalytic activity under physiological conditions, thereby limiting their broader application. We report a single-residue mutant (F762A) of the mesophilic Family A DNA polymerase I Klenow fragment that synthesizes DNA, RNA, 2'-F-RNA, and FANA with yields exceeding 85% at 37°C, as well as 2'-OMe-RNA, HNA, phosphorothioate-, and (methyl) pseudoU-containing oligonucleotides, confirming its broad substrate compatibility. Compared to wild-type, F762A exhibits up to 90-fold higher catalytic efficiency for modified nucleotides while maintaining an overall error rate below 1.19 × 10-3. F762A functions efficiently under physiological metal ion concentrations and molecular crowding, with reverse transcriptase activity and 2'-F-RNA-templated self-replication. Unlike thermophilic XNA polymerases, nearly inactive at 37°C, F762A also extends DNA and RNA primers to generate chimeric XNAs. Molecular dynamics simulations show F762A relieves steric hindrance from the phenylalanine side chain, improving modified nucleotide accommodation while maintaining polymerase structural integrity. These findings establish a foundation for polymerase-mediated XNA synthesis under physiological conditions and expand the potential of XNAs in synthetic biology and biotechnology.

Indexed as

DNA Polymerase INucleotidesProtein EngineeringDNAMutationRNASubstrate SpecificityDNADNA Polymerase INucleotidesRNA

Identifiers

PMID42454372
PMCPMC13369328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.